Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Laboratory Tests Applied for Diagnosing the SARS-CoV-2 Infection

SARS-CoV-2 감염의 진단에 이용되는 검사실 테스트의 비교

  • Lee, Chang-Gun (Department of Medical Genetics, Ajou University School of Medicine) ;
  • Lee, Dongsup (Department of Clinical Laboratory Science, Hyejeon College)
  • 이창근 (아주대학교 의과대학 의학유전학과) ;
  • 이동섭 (혜전대학교 임상병리과)
  • Received : 2022.04.21
  • Accepted : 2022.05.13
  • Published : 2022.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Due to the highly contagious nature and severity of the respiratory diseases caused by COVID-19, economical and accurate tests are required to better monitor and prevent the spread of this contagion. As the structural and molecular properties of SARS-CoV-2 were being revealed during the early stage of the COVID-19 pandemic, many manufacturers of COVID-19 diagnostic kits actively invested in the design, development, validation, verification, and implementation of diagnostic tests. Currently, diagnostic tests for SARS-CoV-2 are the most widely used and validated techniques for rapid antigen, and immuno-serological assays for specific IgG and IgM antibody tests and molecular diagnostic tests. Molecular diagnostic assays are the gold standard for direct detection of viral RNA in individuals suspected to be infected with SARS-CoV-2. Antibody-based serological tests are indirect tests applied to determine COVID-19 prevalence in the community and identify individuals who have obtained immunity. In the future, it is necessary to explore technical problems encountered in the early stages of global or regional outbreaks of pandemics and provide future directions for better diagnostic tests. This article evaluates the commercially available and FDA-approved molecular and immunological diagnostic assays and analyzes their performance characteristics.

COVID-19로 인한 높은 전염성과 호흡기 질환의 심각성 때문에, 전염의 확산을 더 잘 모니터링하고 예방하기 위해 경제적이고 정확한 검사가 필요하다. COVID-19 대유행의 초기 단계에서 SARS-CoV-2의 구조적 및 분자적 특성이 밝혀짐에 따라, 많은 COVID-19 진단 키트 제조업체들은 진단 테스트의 설계, 개발, 검증 및 구현에 적극적으로 투자했다. 현재, SARS-CoV-2에 대한 진단검사로써 신속한 항원, 특정 IgG 및 IgM 항체검사를 위한 면역 혈청학적 검사 그리고 분자 진단 검사가 가장 널리 사용되고 검증된 기술이다. 분자 진단 분석법은 SARS-CoV-2에 감염된 것으로 의심되는 개인에서 바이러스 RNA를 직접 검출하기 위한 gold standard이다. 항체 기반 혈청 검사는 지역사회에서 COVID-19 유병률을 결정하고 면역력을 획득한 개인을 식별하는 데 사용되는 간접 검사이다. 본 논문에서는 시판되고 FDA가 승인한 분자 및 면역학적 진단 측정을 평가하여 성능 특성을 분석하였다.

Keywords

Acknowledgement

This research was supported by Hyejeon College grant.

References

  1. Kim EJ, Lee D. Coronaviruses: SARS, MERS and COVID-19. Korean J Clin Lab Sci. 2020;52:297-309. https://doi.org/10.15324/kjcls.2020.52.4.297
  2. Yang BS, Choi SM, Bae HJ, Kim YS, Lim Y, Kang HJ, et al. The role and focus areas of medical technologists in the field of diagnostic tests in the COVID-19 era. Korean J Clin Lab Sci. 2022;54:49-60. https://doi.org/10.15324/kjcls.2022.54.1.49
  3. Habli Z, Saleh S, Zaraket H, Khraiche ML. COVID-19 in-vitro diagnostics: state-of-the-art and challenges for rapid, scalable, and high-accuracy screening. Front Bioeng Biotechnol. 2021;8:1-14. https://doi.org/10.3389/fbioe.2020.605702
  4. Ravi N, Cortade DL, Ng E, Wang SX. Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape. Biosens Bioelectron. 2020;165:112454. https://doi.org/10.1016/j.bios.2020.112454
  5. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2020:1-14. https://doi.org/10.1038/s41579-020-00459-7
  6. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565-574. https://doi.org/10.1016/S0140-6736(20)30251-8
  7. Diaz DA, Munoz CF, Donato KL, Ciro JU, Sierra NF, Sanchez AF, et al. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia. Infect Genet Evol. 2020;84:104390. https://doi.org/10.1016/j.meegid.2020.104390
  8. Falzone L, Gattuso G, Tsatsakis A, Spandidos DA, Libra M. Current and innovative methods for the diagnosis of COVID-19 infection (Review). Int J Mol Med. 2021;47:100. https://doi.org/10.3892/ijmm.2021.4933
  9. Lang FM, Lee KM, Teijaro JR, Becher B, Hamilton JA. GM-CSF-based treatments in COVID-19: Reconciling opposing therapeutic approaches. Nat Rev Immunol. 2020;20:507-514. https://doi.org/10.1038/s41577-020-0357-7
  10. Rong G, Zheng Y, Chen Y, Zhang Y, Zhu P, Sawana M. COVID-19 diagnostic methods and detection techniques: A review. Reference Module in Biomedical Sciences. 2021:B978-0-12-822548-6.00080-7. https://doi.org/10.1016/B978-0-12-822548-6.00080-7
  11. Zhang Y, Wang C, Han M, Ye J, Gao Y, Liu Z, et al. Discrimination of false negative results in RT-PCR detection of SARS-CoV-2 RNAs in clinical specimens by using an internal reference. Virol Sin. 2020;35:758-767. https://doi.org/10.1007/s12250-020-00273-8
  12. Jacofsky D, Jacofsky EM, Jacofsky M. Understanding antibody testing for COVID-19. J Arthroplasty. 2020;35:S74-S81. https://doi.org/10.1016/j.arth.2020.04.055
  13. To KW, Tsang OY, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect Dis. 2020;20:565-574. https://doi.org/10.1016/S1473-3099(20)30196-1
  14. Tan W, Lu Y, Zhang J, Wang J, Dan Y, Tan Z, et al. Viral kinetics and antibody responses in patients with COVID-19. medRxiv. 2020. https://doi.org/10.1101/2020.03.24.20042382
  15. Renard N, Daniel S, Cayet N, Pecquet M, Raymond F, Pons S, et al. Performance characteristics of the vidas SARS-CoV-2 IgM and IgG serological assays. J Clin Microbiol. 2021;59:e02292-20. https://doi.org/10.1128/JCM.02292-20
  16. Demey B, Daher N, Francois C, Lanoix JP, Duverlie G, Castelain S, et al. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. J Infect. 2020;81:e6-e10. https://doi.org/10.1016/j.jinf.2020.04.033
  17. Hsieh WY, Lin CH, Lin TC, Lin CH, Chang HF, Tsai CH, et al. Development and efficacy of lateral flow point-of-care testing devices for rapid and mass COVID-19 diagnosis by the detections of SARS-CoV-2 antigen and anti-SARS-CoV-2 antibodies. Diagnostics. 2021;11:1760. https://doi.org/10.3390/diagnostics11101760
  18. Tali SS, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. ASM Journals. 2021;34:e00228-20. https://doi.org/10.1128/CMR.00228-20
  19. Song GS, Lee YR, Kim S, Kim W, Choi J, Yoo D, et al. Laboratory diagnosis of coronavirus disease 19 (COVID-19) in Korea: Current status, limitation, and challenges. Korean J Clin Lab Sci. 2020;52:284-295. https://doi.org/10.15324/kjcls.2020.52.3.284
  20. Toropov N, Osborne E, Joshi LT, Davidson J, Morgan C, Page J, et al. SARS-CoV-2 tests: Bridging the gap between laboratory sensors and clinical applications. ACS Sens. 2021;6:2815-2837. https://doi.org/10.1021/acssensors.1c00612
  21. Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, et al. Diagnostics for SARS-CoV-2 infections. Nat Mater. 2021;20:593-605. https://doi.org/10.1038/s41563-020-00906-z
  22. Younes N, Sadeq DW, Jighefee HA, Younes S, Jamal OA, Daas HI, et al. Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses. 2020;12:582. https://doi.org/10.3390/v12060582
  23. Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VC, et al. Diagnosing COVID-19: The disease and tools for detection. ACS Nano. 2020:acsnano.0c02624. https://doi.org/10.1021/acsnano.0c02624
  24. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
  25. List of COVID-19 diagnostic devices approved by MFDS [Internet]. Osong: Ministry of Food and Drug Safety; 2022 [cited 2022 May 5]. Available from: https://www.mfds.go.kr/docviewer/skin/doc.html?fn=20220503062003939.pdf&rs=/docviewer/result/ntc0003/44348/2/202205
  26. Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8:CD013705. https://doi.org/10.1002/14651858.CD013705
  27. James AS, Alwneh JI. COVID-19 Infection diagnosis: Potential impact of isothermal amplification technology to reduce community transmission of SARS-CoV-2. Diagnostics. 2020;10:399. https://doi.org/10.3390/diagnostics10060399
  28. Li J, Macdonald J, von Stetten F. Review: A comprehensive summary of a decade development of the recombinase polymerase amplification. Analyst. 2018;144:31-67. https://doi.org/10.1039/c8an01621f
  29. Lau YL, Ismail IB, Mustapa NB, Lai MY, Soh TT, Hassan AH, et al. Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). PLoS One. 2021;16:e0245164. https://doi.org/10.1371/journal.pone.0245164
  30. Behrmann O, Bachmann I, Spiegel M, Schramm M, Wahed AE, Dobler G, et al. Rapid detection of SARS-CoV-2 by low volume real-time single tube reverse transcription recombinase polymerase amplification using an exo probe with an internally linked quencher (Exo-IQ). Clin Chem. 2020;66:1047-1054. https://doi.org/10.1093/clinchem/hvaa116
  31. Smith E, Zhen W, Manji R, Schron D, Duong S, Berry GJ. Analytical and clinical comparison of three nucleic acid amplification tests for SARS-CoV-2 detection. J Clin Microbiol. 2020;58:e01134-20. https://doi.org/10.1128/JCM.01134-20
  32. Qian C, Wang R, Wu H, Ji F, Wu J. Nicking enzyme-assisted amplification (NEAA) technology and its applications: A review. Anal Chim Acta. 2019;1050:1-15. https://doi.org/0.1016/j.aca.2018.10.054 https://doi.org/10.1016/j.aca.2018.10.054
  33. Alves PA, de Oliveira EG, Luiz AF, Almeida LT, Goncalves AB, Borges IA, et al. Optimization and clinical validation of colorimetric reverse transcription loop-mediated isothermal amplification, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern. Front Microbiol. 2021;12:713713. https://doi.org/10.3389/fmicb.2021.713713
  34. Moore KM, Cahill J, Aidelberg G, Aronoff R, Bektas A, Bezdan D, et al. Loop-Mediated isothermal amplification detection of SARS-CoV-2 and myriad other applications. J Biomol Tech. 2021;32:228-275. https://doi.org/10.7171/jbt.21-3203-017
  35. Lee CJ, Shin WS, Mun SY, Yu MJ, Choi YB, Kim DH, et al. Diagnostic evaluation of qRT-PCR-based kit and dPCR-based kit for COVID-19. Genes Genomics. 2021;43:1277-1288. https://doi.org/10.1007/s13258-021-01162-4
  36. Ali Z, Aman R, Mahas A, Rao GS, Tehseen M, Marsic T, et al. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2. Virus Res. 2020;288:198129. https://doi.org/10.1016/j.virusres.2020.198129
  37. Guo L, Sun X, Wang X, Liang C, Jiang H, Gao Q, et al. SARS-CoV-2 detection with CRISPR diagnostics. Cell Discov. 2020;6:34. https://doi.org/10.1038/s41421-020-0174-y
  38. Hess JF, Kohl TA, Kotrova M, Ronsch K, Paprotka T, Mohr V, et al. Library preparation for next generation sequencing: A review of automation strategies. Biotechnol Adv. 2020;41:107537. https://doi.org/10.1016/j.biotechadv.2020.107537
  39. Bhoyar RC, Jain A, Sehgal P, Divakar MK, Sharma D, Imran M, et al. High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing. PLoS One. 2021;16:e0247115. https://doi.org/10.1371/journal.pone.0247115
  40. Bloom JS, Sathe L, Munugala C, Jones EM, Gasperini M, Lubock NB, et al. Swab-Seq: A high-throughput platform for massively scaled up SARS-CoV-2 testing. medRxiv. 2020:20167874. https://doi.org/10.1101/2020.08.04.20167874
  41. Hilaire BS, Durand NC, Mitra N, Pulido SG, Mahajan R, Blackburn A, et al. A rapid, low cost, and highly sensitive SARS-CoV-2 diagnostic based on whole genome sequencing. bioRxiv. 2020:061499. https://doi.org/10.1101/2020.04.25.061499
  42. Jary A, Leducq V, Malet I, Marot S, Frutos EK, Teyssou E, et al. Evolution of viral quasispecies during SARS-CoV-2 infection. Clin Microbiol Infect. 2020;26:1560.e1-1560.e4. https://doi.org/10.1016/j.cmi.2020.07.032
  43. Mak GK, Lau SY, Wong KY, Chow NS, Lau CS, Lam EK, et al. Evaluation of rapid antigen detection kit from the WHO emergency use list for detecting SARS-CoV-2. J Clin Virol. 2021;134:104712. https://doi.org/10.1016/j.jcv.2020.104712
  44. Interim guidance of World Health Organization, Antigen-Detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays interim guidance [Internet]. Geneva: World Health Organization; 2021 [cited 2021 October 6]. Available from: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays
  45. Yun SG, Ko DH, Kim YE, Roh KH, Lee JH, Cho JH, et al. Initial response of the Korean society for laboratory medicine to the COVID-19 pandemic. Lab Med Online. 2021;11:217-222. https://doi.org/10.47429/lmo.2021.11.4.217
  46. Mak GK, Cheng PC, Lau SY, Wong KY, Lau CS, Lam ET, et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol. 2020;129:104500. https://doi.org/10.1016/j.jcv.2020.104500
  47. Yadav S, Sadique MA, Ranjan P, Kumar N, Singhal A, Srivastava AK, et al. SERS based lateral flow immunoassay for point-of-care detection of SARS-CoV-2 in clinical samples. ACS Appl Bio Mater. 2021;4:2974-2995. https://doi.org/10.1021/acsabm.1c00102
  48. Liotti FM, Menchinelli G, Lalle E, Palucci I, Marchetti S, Colavita F, et al. Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples. Clin Microbiol Infect. 2021;27:487-488. https://doi.org/10.1016/j.cmi.2020.09.030
  49. Korenkov M, Poopalasingam N, Madler M, Vanshylla K, Eggeling R, Wirtz M, et al. Evaluation of a rapid antigen test to detect SARS-CoV-2 infection and identify potentially infectious individuals. J Clin Microbiol. 2021;59:e00896-21. https://doi.org/10.1128/JCM.00896-21
  50. Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-948. https://doi.org/10.1080/22221751.2020.1762515
  51. Espejo AP, Akgun Y, Mana AA, Tjendra Y, Millan NC, Fernandez CG, et al. Review of current advances in serologic testing for COVID-19. Am J Clin Pathol. 2020;154:293-304. https://doi.org/10.1093/ajcp/aqaa112
  52. Filchakova O, Dossym D, Ilyas A, Kuanysheva T, Abdizhamil A, Bukasov R. Review of COVID-19 testing and diagnostic methods. Talanta. 2022;244:123409. https://doi.org/10.1016/j.talanta.2022.123409
  53. Alpdagtas S, Ilhan E, Uysal E, Sengor M, Ustundag CB, Gunduz O. Evaluation of current diagnostic methods for COVID-19. APL Bioeng. 2020;4:041506. https://doi.org/10.1063/5.0021554
  54. Burbelo PD, Riedo FX, Morishima C, Rawlings S, Smith D, Das S, et al. Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to spike protein in COVID-19 patients. medRxiv. 2020:20071423. https://doi.org/10.1101/2020.04.20.20071423
  55. Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, et al. Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev. 2020;6:CD013652. https://doi.org/10.1002/14651858.CD013652
  56. Norman M, Gilboa T, Ogata AF, Maley AM, Cohen L, Cai Y, et al. Ultra-sensitive high-resolution profiling of anti-SARS-CoV-2 antibodies for detecting early seroconversion in COVID-19 patients. medRxiv. 2020:20083691. https://doi.org/10.1101/2020.04.28.20083691
  57. Choi DO, Lee KM. Development of COVID-19 neutralizing antibody (NAb) detection kits using the S1 RBD protein of SARS-CoV-2. Korean J Clin Lab Sci. 2021;53:257-265. https://doi.org/10.15324/kjcls.2021.53.3.257
  58. Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021;19:171-183. https://doi.org/10.1038/s41579-020-00461-z
  59. Ghaffari A, McGill I, Ardakani A. Trends in COVID-19 diagnostic test development [Internet]. Bioprocess Int. 2020 [cited 2020 June 11]. Available from: https://bioprocessintl.com/analytical/diagnostics/trends-in-development-of-covid-19-diagnostic-tests
  60. Carter LJ, Garner LV, Smoot JW, Li Y, Zhou Q, Saveson CJ, et al. Assay techniques and test development for COVID-19 diagnosis. ACS Cent Sci. 2020;6:591-605. https://doi.org/10.1021/acscentsci.0c00501